Copyright
©2013 Baishideng Publishing Group Co.
World J Diabetes. Dec 15, 2013; 4(6): 358-364
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.358
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.358
Figure 1 Glycosylated hemoglobin A1c changes from pre- to post-Ramadan period (A) and percentage of patients who achieved target glycosylated hemoglobin A1c < 7.
0% (B). aP < 0.05, bP = 0.009. Vildagliptin group: Patients receiving vildagliptin ± metformin; Sulfonylurea group: Patients receiving sulfonylurea ± metformin; HbA1c: Glycosylated hemoglobin A1c.
Figure 2 Mean body weight at pre- and post-Ramadan period.
aP < 0.01. Vildagliptin group: Patients receiving vildagliptin ± metformin; Sulfonylurea group: Patients receiving sulfonylurea ± metformin.
-
Citation: Shete A, Shaikh A, Nayeem KJ, Rodrigues L, Ali MSS, Shah P, Khanna R, Majid S, Rasheed SA, Shaikh S, Rahman T. Vildagliptin
vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan. World J Diabetes 2013; 4(6): 358-364 - URL: https://www.wjgnet.com/1948-9358/full/v4/i6/358.htm
- DOI: https://dx.doi.org/10.4239/wjd.v4.i6.358